These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20728278)

  • 1. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity.
    Costa B; Da Pozzo E; Chelli B; Simola N; Morelli M; Luisi M; Maccheroni M; Taliani S; Simorini F; Da Settimo F; Martini C
    Psychoneuroendocrinology; 2011 May; 36(4):463-72. PubMed ID: 20728278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
    Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
    Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.
    Simorini F; Marini AM; Taliani S; La Motta C; Salerno S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2012; 12(4):333-51. PubMed ID: 22204487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocator protein as a promising target for novel anxiolytics.
    Costa B; Da Pozzo E; Martini C
    Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
    Nothdurfter C; Rammes G; Baghai TC; Schüle C; Schumacher M; Papadopoulos V; Rupprecht R
    J Neuroendocrinol; 2012 Jan; 24(1):82-92. PubMed ID: 21609361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.
    Wolf L; Bauer A; Melchner D; Hallof-Buestrich H; Stoertebecker P; Haen E; Kreutz M; Sarubin N; Milenkovic VM; Wetzel CH; Rupprecht R; Nothdurfter C
    Pharmacopsychiatry; 2015 Mar; 48(2):72-7. PubMed ID: 25654303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
    Nothdurfter C; Baghai TC; Schüle C; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S107-12. PubMed ID: 22923187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa).
    Zhang LM; Zhao N; Guo WZ; Jin ZL; Qiu ZK; Chen HX; Xue R; Zhang YZ; Yang RF; Li YF
    Neuropharmacology; 2014 Jun; 81():116-25. PubMed ID: 24067925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocator protein ligands as promising therapeutic tools for anxiety disorders.
    Taliani S; Da Settimo F; Da Pozzo E; Chelli B; Martini C
    Curr Med Chem; 2009; 16(26):3359-80. PubMed ID: 19548867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in potential anxiolytic agents targeting GABAA/BzR complex or the translocator protein (18kDa) (TSPO).
    Nothdurfter C; Rupprecht R; Rammes G
    Curr Top Med Chem; 2012; 12(4):360-70. PubMed ID: 22204486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAA and 5HT receptors.
    Ghisleni G; Kazlauckas V; Both FL; Pagnussat N; Mioranzza S; Rocha JB; Souza DO; Porciúncula LO
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1508-15. PubMed ID: 18579279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal exposure to estradiol in rats influences neuroactive steroid concentrations, GABAA receptor expression, and behavioral sensitivity to anxiolytic drugs.
    Calza A; Sogliano C; Santoru F; Marra C; Angioni MM; Mostallino MC; Biggio G; Concas A
    J Neurochem; 2010 Jun; 113(5):1285-95. PubMed ID: 20345753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.
    Costa B; Da Pozzo E; Giacomelli C; Barresi E; Taliani S; Da Settimo F; Martini C
    Sci Rep; 2016 Jan; 6():18164. PubMed ID: 26750656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold.
    Cappelli A; Bini G; Valenti S; Giuliani G; Paolino M; Anzini M; Vomero S; Giorgi G; Giordani A; Stasi LP; Makovec F; Ghelardini C; Di Cesare Mannelli L; Concas A; Porcu P; Biggio G
    J Med Chem; 2011 Oct; 54(20):7165-75. PubMed ID: 21916402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice.
    Kita A; Furukawa K
    Pharmacol Biochem Behav; 2008 Apr; 89(2):171-8. PubMed ID: 18201755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like activity of SB-205384 in the elevated plus-maze test in mice.
    Navarro JF; Burón E; Martín-López M
    Psicothema; 2006 Feb; 18(1):100-4. PubMed ID: 17296016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependence of anxiolytic effects of the dipeptide TSPO ligand GD-23 on neurosteroid biosynthesis.
    Gudasheva TA; Deeva OA; Yarkova MA; Seredenin SB
    Dokl Biochem Biophys; 2016 Jul; 469(1):298-301. PubMed ID: 27599516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.